Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR plus breast cancer in the TEAM trial.

被引：0

作者：

Bartlett, John M. S.

Xu, Keying

Wong, Jenna

Pond, Gregory Russell

Zhang, Yi

Spears, Melanie

Salunga, Ranelle C.

Mallon, Elizabeth

Taylor, Karen J.

Hasenburg, Annette

Markopoulos, Christos

Dirix, Luc Yves

Seynaeve, Caroline M.

Van de Velde, Cornelis J. H.

Rea, Daniel William

Schnabel, Catherine A.

Treuner, Kai

Bayani, Jane

机构：

[1] Univ Edinburgh, Canc Res UK Scotland Ctr, Edinburgh, Midlothian, Scotland

[2] Unity Hlth Toronto, Toronto, ON, Canada

[3] A Holog Co, Biotheranost, San Diego, CA USA

[4] McMaster Univ, Hamilton, ON, Canada

[5] Ontario Inst Canc Res, Toronto, ON, Canada

[6] Dept Pathol, Glasgow, Lanark, Scotland

[7] Univ Med Ctr Mainz, Mainz, Germany

[8] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece

[9] GZA Ziekenhuizen Antwerpen Campus Sint Augustinus, Antwerp, Belgium

[10] Erasmus MC, Kanker Inst Locatie Daniel Hoed, Rotterdam, Netherlands

[11] Leiden Univ Med Ctr, Leiden, Netherlands

[12] Univ Birmingham, Canc Res UK Clin Trials Unit CRCTU, Birmingham, W Midlands, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

509

引用

页数：1

共 50 条

[31] AnastrozoleA Review of its Use in Postmenopausal Women with Early-Stage Breast Cancer
Mark Sanford
Greg L. Plosker
[J]. Drugs, 2008, 68 : 1319 - 1340
[32] Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer
Reinhorn, Daniel
Yerushalmi, Rinat
Moore, Assaf
Desnoyers, Alexandra
Saleh, Ramy R.
Amir, Eitan
Goldvaser, Hadar
[J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (02) : 259 - 266
[33] Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer
Reinhorn, D. J.
Amir, E.
Yerushalmi, R.
Goldvaser, H.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[34] Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer
Daniel Reinhorn
Rinat Yerushalmi
Assaf Moore
Alexandra Desnoyers
Ramy R. Saleh
Eitan Amir
Hadar Goldvaser
[J]. Breast Cancer Research and Treatment, 2020, 182 : 259 - 266
[35] Tamoxifen versus tamoxifen plus octreotide LAR as adjuvant therapy for early-stage breast cancer in postmenopausal women: Update of NCIC CTG MA14 trial.
Pollak, M. N.
Chapman, J. W.
Pritchard, K. I.
Krook, J. E.
Dhaliwal, H. S.
Vandenberg, T. A.
Whelan, T. J.
O'Reilly, S. E.
Wilson, C. F.
Shepherd, L. E.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[36] Accuracy of Perceived Risk of Recurrence Among Patients With Early-Stage Breast Cancer
Liu, Ying
Perez, Maria
Aft, Rebecca L.
Massman, Kerry
Robinson, Erica
Myles, Stephanie
Schootman, Mario
Gillanders, William E.
Jeffe, Donna B.
[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (03) : 675 - 680
[37] Risk of Recurrence in Early-Stage, HER2-Positive Breast Cancer
Isaacs, Claudine
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 3 - 6
[38] Breast Cancer Index (BCI) prognostic and predictive classification in older versus younger patients with early-stage HR plus breast cancer (BC) and correlation with clinical risk factors.
Yuan, Yuan
Cao, Yu
Israel, Mason
Liu, Junmei
Schnabel, Catherine A.
Hurria, Arti
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[39] Integration of breast cancer index (BCI) with clinicopathological factors for prediction of distant recurrence in ER plus breast cancer
Sestak, Ivana
Zhang, Yi
Schroeder, Brock E.
Goss, Paul E.
Dowsett, Mitch
Sgroi, Dennis C.
Schnabel, Catherine A.
Cuzick, Jack
[J]. CANCER RESEARCH, 2015, 75
[40] PAIN, PHYSICAL ACTIVITY, AND CARDIORESPIRATORY FITNESS IN POSTMENOPAUSAL WOMEN WITH EARLY-STAGE BREAST CANCER
Cummings, Meredith
Erickson, Kirk
Genrty, Amanda
Rosenzweig, Peg
Sereika, Susan
Bender, Cathy
[J]. ONCOLOGY NURSING FORUM, 2021, 48 (02) : 44 - 44

← 1 2 3 4 5 →